Although the latter aspects have not been addressed here, it would be highly interesting to determine whether targeting the CXCR4-axis, either directly or indirectly through CD74, will lead to improved therapeutic efficacy in T1D models. The gene discussed is CXCR4; the disease is type 1 diabetes mellitus.